Mapping large numbers of results may take a few moments.
Search Results
Showing 1 - 50 of 321 results found.
| Company | Activity | Company Description | Location | |
|---|---|---|---|---|
 |
Company APIE Therapeutics Inc. | Activity: Research and Development | Company Description APIE Therapeutics is developing therapies for fibrosis and related diseases. Its biology platform is the activation of the Apelinergic System signaling pathway via Apelin/APJ receptors agonist drug therapies. | Location Cary |
|
Company Propella Therapeutics Inc. | Activity: Research and Development | Company Description Propella Therapeutics is a privately held development stage company developing treatments for chronic joint pain due to osteoarthritis and prostate cancer. Its pipeline of patented candidates include Phase-3 ready CGS-200-5, and PRL-02. | Location Pittsboro |
|
Company StrideBio Inc. | Activity: Research and Development | Company Description StrideBio develops engineered viral vectors for gene therapy for the treatment of rare diseases. StrideBio's technology engine utilizes structure-inspired design to engineer AAV vectors which can escape pre-existing neutralizing antibodies (NAbs). | Location Research Triangle Park |
| |
Company 9 Meters Biopharma | Activity: Sales and Operations | Company Description 9 Meters Biopharma in-licenses, develops and commercializes therapeutics for rare and orphan gastrointestinal diseases. | Location Raleigh |
| |
Company Accord Healthcare Inc. | Activity: Sales and Operations | Company Description Accord Healthcare is the marketing subsidiary of Intas Pharmaceuticals, an India-based company that focuses on manufacturing generic pharmaceuticals and biosimilars for the global market. | Location Durham |
| |
Company Aceragen Inc. | Activity: Research and Development | Company Description Aceragen is a drug development company advancing a late-stage therapy for Farber disease | Location Research Triangle Park |
| |
Company Achelios Therapeutics Inc. | Activity: Research and Development | Company Description Achelios Therapeutics develops novel topical therapies for inflammatory pain, such as joint, muscle temporomandibular and migraine pain. | Location Durham |
| |
Company Adrenas Therapeutics Inc. | Activity: Research and Development | Company Description Adrenas Therapeutics, a Bridge Bio subsidiary, is developing a gene therapy for the treatment of a monogenic disease that presents in childhood. | Location Raleigh |
| |
Company Adroit Pharmaceutical Development LLC | Activity: Contract Research and Testing | Company Description Adroit Pharmaceutical Development identifies new and improved formulations and process technologies. Its primary focus is on inhalation and dermatological product development. | Location Durham |
| |
Company AegisCN LLC | Activity: Research and Development | Company Description AegisCN develops technologies and treatments targeting neurological diseases and inflammation. | Location Durham |
| |
Company Aerami Therapeutics | Activity: Research and Development | Company Description Aerami Therapeutics develops soft mist inhaled formulations of biologics and inhalation devices to treat severe and chronic diseases. Its first product is for the treatment of diabetes. | Location Durham |
| |
Company Aerie Pharmaceuticals Inc. | Activity: Research and Development | Company Description Aerie Pharmaceuticals discovers, develops and commercializes first-in-class therapies for the treatment of patients with glaucoma, dry eye, retinal diseases and other diseases of the eye. | Location Durham |
| |
Company Aestas Pharma Inc. | Activity: Research and Development | Company Description Asetas Pharma develops novel diagnostic imaging and disease-modifying therapeutic agents to enable the early treatment and reversal of Alzheimer’s and Parkinson’s disease when clinical signs are not yet pronounced. | Location Durham |
| |
Company Agile Sciences Inc. | Activity: Research and Development | Company Description Agile Sciences is developing small molecules that inhibit bacterial resistance through a novel mode of action that enhances antibiotic activity. | Location Raleigh |
| |
Company AimMax Therapeutics Inc. | Activity: Research and Development | Company Description AimMax Therapeutics researches and develops biopharmaceuticals for the treatment of infection, inflammation and pain through in-licensing or co-development with strategic partners. | Location Durham |
| |
Company Alcami Corporation | Activity: Production and Manufacturing | Company Description Alcami provides contract drug and biologics development and manufacturing services, including formulation development, analytical chemistry, API, solid dose and parenteral drug manufacturing for both clinical and commercial markets. | Location Wilmington |
| |
Company Alcami Corporation (Durham) | Activity: Contract Research and Testing | Company Description Alcami provides contract drug and biologics development and manufacturing services, including formulation development, analytical chemistry, API, solid dose and parenteral drug manufacturing for clinical and commercial markets. Alcami's HQ is in Durham. | Location Durham |
| |
Company AlphaVax Inc. | Activity: Research and Development | Company Description AlphaVax develops vaccine technology with applications in infectious disease, cancer and biodefense threats. | Location Research Triangle Park |
| |
Company Altavant Sciences Inc. | Activity: Research and Development | Company Description Altavant is a clinical stage biopharmaceutical company developing therapies for rare respiratory diseases. Altavant's therapeutic focus is in pulmonary arterial hypertension (PAH) and bronchiolitis obliterans syndrome (BOS). | Location Cary |
| |
Company Alterna Therapeutics Inc. | Activity: Research and Development | Company Description Alterna Therapeutics is developing first-in-class small molecules targeting the SHIP enzyme. Alterna is exploring its lead compounds in the areas of obesity, diabetes, bone marrow transplant and post-myeloblative therapy, cancer and Alzheimer's disease. | Location Durham |
| |
Company Amalgent Therapeutics LLC | Activity: Research and Development | Company Description Amalgent is a clinical-stage company developing oral pain management therapeutics. | Location Chapel Hill |
| |
Company AMO Pharma Ltd. | Activity: Research and Development | Company Description AMO Pharma is developing new treatments for serious and debilitating diseases including rare genetic disorders. | Location Durham |
| |
Company Aniluxx Biotechnology Inc. | Activity: Research and Development | Company Description Aniluxx Biotechnology translates human therapies to dogs, cats and horses to treat itching and pain. | Location Chapel Hill |
| |
Company ARC Therapeutics LLC | Activity: Research and Development | Company Description ARC Therapeutics is developing novel cancer treatments through the selective inhibition of specific CDK (cyclin-dependent kinase) family members to address unmet medical needs of oncology patients. | Location Research Triangle Park |
| |
Company Ardeal Pharma Inc. | Activity: Research and Development | Company Description Ardeal Pharma is a virtual pharma company developing patented stabilized sulforaphane for the dermal pharmaceutical and cosmetic markets. | Location Brevard |
| |
Company Ardeal Research Institute | Activity: Research and Development | Company Description Ardeal Research Institute is a non-profit organization that develops drug discovery capabilities of the natural resources in Western North Carolina. The Institute has collaboration agreements in place with Brevard College and the N.C. Arboretum. | Location Brevard |
| |
Company Arrevus Inc. | Activity: Research and Development | Company Description Arrevus is a clinical stage biotechnology company developing novel therapeutics for unmet medical needs in infectious disease and oncology. | Location Butner |
| |
Company Arrivo BioVentures LLC | Activity: Research and Development | Company Description Arrivo BioVentures accelerates biologics and small molecules from IND readiness through a clinical proof of concept, with biologics in development for dermatologic conditions. | Location Morrisville |
| |
Company Aruna Bio | Activity: Research and Development | Company Description Aruna Bio develops neural exosomes for the treatment of neurodegenerative diseases. The company is utilizing its proprietary neural exosome platform and manufacturing capability to develop a pipeline of therapeutics. | Location Raleigh |
| |
Company Asinex | Activity: Contract Research and Testing | Company Description Asinex designs small-molecule libraries and provides lead optimization, custom synthesis and other chemistry services. The Winston-Salem location is the company's U.S. headquarters. | Location Winston-Salem |
| |
Company AskBio | Activity: Research and Development | Company Description Asklepios BioPharmaceutical (AskBio) uses adeno-associated virus (AAV) technology to develop and manufacture gene therapies for rare diseases and other genetic disorders. | Location Research Triangle Park |
| |
Company Asymchem Inc. | Activity: Sales and Operations | Company Description Asymchem offers CMC and CDMO services, focused on developing processes for late-phase to commercial APIs and HPAPIs, and small-molecule manufacturing and development. Asymchem is USFDA- and TGA-inspected. | Location Morrisville |
| |
Company Atox Bio Inc. | Activity: Research and Development | Company Description Atox Bio develops novel immunomodulators to treat critically ill patients. Therapeutic indications include necrotizing soft tissue infections. | Location Durham |
| |
Company Atsena Therapeutics Inc. | Activity: Research and Development | Company Description Atsena Therapeutics is developing ocular gene therapies to reverse or prevent blindness. | Location Durham |
| |
Company Auration Biotech Inc. | Activity: Research and Development | Company Description Auration Biotech is developing novel therapeutics for ear, nose and throat diseases. | Location Chapel Hill |
| |
Company Aurobindo Pharma USA Inc. | Activity: Research and Development | Company Description Aurobindo Pharma is a generic drug manufacturer. Aurobindo develops inhalation and dermatological products from the company's U.S. research and development headquarters in North Carolina. | Location Durham |
| |
Company Avicenna Therapeutics | Activity: Research and Development | Company Description Avicenna Therapeutics is developing NOSH-platform eNSAIDs to treat cancer. | Location Raleigh |
| |
Company Avior Inc. | Activity: Research and Development | Company Description Avior is developing a nanoparticle-based drug delivery technology to deliver lipophilic drugs with high bioavailability. It is testing its technology using a molecule for the treatment of pruritus in chronic kidney disease. | Location Durham |
| |
Company Avolynt Inc. | Activity: Research and Development | Company Description Avolynt is developing therapeutics for rare and metabolic disease. Avolynt's lead programs target Type 2 diabetes, NASH and Post Bariatric Hypoglycemia. | Location Research Triangle Park |
| |
Company Balanced pHarma Inc. | Activity: Research and Development | Company Description Balanced pHarma is developing a pH-balanced dental anesthetic drug. | Location Cornelius |
| |
Company Ballek Biologics LLC | Activity: Research and Development | Company Description Ballek Biologics is developing a therapeutic to reverse opioid overdose. | Location Raleigh |
| |
Company Banner Life Sciences LLC | Activity: Research and Development | Company Description Banner Life Sciences develops formulation technologies (gelcaps, tablets and sterile injectables) and licenses and markets prescription, over-the-counter and nutritional products. | Location High Point |
| |
Company Basking Biosciences Inc. | Activity: Research and Development | Company Description Basking Biosciences is developing a reversible anti-thrombotic therapeutic to treat ischemic stroke. | Location Research Triangle Park |
| |
Company Bavarian Nordic Inc. | Activity: Research and Development | Company Description Bavarian Nordic develops, manufactures and commercializes cancer immunotherapies and vaccines for infectious diseases. | Location Morrisville |
| |
Company BD Technologies and Innovation | Activity: Research and Development | Company Description BD Technologies and Innovation develops technologies for parenteral drug delivery, advanced diagnostics, smart medical devices and genomic research and supports external innovation. The RTP site is BD's corporate technology R&D and innovation center. | Location Research Triangle Park |
| |
Company BE Pharmaceuticals USA Inc. | Activity: Sales and Operations | Company Description BE Pharmaceuticals USA is the US office for Biological E Ltd., a vaccine manufacturing company headquartered in India. | Location Cary |
| |
Company Beam Therapeutics | Activity: Production and Manufacturing | Company Description Beam Therapeutics will manufacture precision genetic medicines through the use of base editing technology at its RTP site. | Location Durham |
| |
Company Bedrock Therapeutics Inc. | Activity: Research and Development | Company Description Bedrock Therapeutics is an AAV research and development company developing platform technologies and therapeutics. | Location Raleigh |
| |
Company Belhaven Biopharma Inc. | Activity: Research and Development | Company Description Belhaven Biopharma is developing dry powder nasal products for a variety of indications. | Location Raleigh |
| |
Company BestCo Inc. | Activity: Production and Manufacturing | Company Description BestCo manufactures over-the-counter drugs and dietary supplements and offers contract product manufacturing and packaging. | Location Mooresville |